ArticlePDF Available

Abstract and Figures

ABSTRACT Background: world is facing explosive increase in diabetes mellitus. It poses a serious challenge to primary health care in developing countries, with negative consequences on the economy. This research is aim at evaluating the effect of Persea americana aqueous seed extract on alloxan induced diabetes rats. Methodology: Effects of the aqueous extract on groups of alloxan (150mg/Kg) induced diabetic rats was investigated. The blood sugar and body weight of the rats was recorded at two weeks and four weeks interval, and one week after the withdrawal of the extract. The test groups (III, IV, and V) were treated with 400mg, 800mg and 1200mg/kg body weight of the extract for 4 weeks. Results: A significant decrease (P<0.001) in blood glucose were observed in all groups compared to Group II. A significant increase in blood glucose (p<0.05) was observed one week after withdrawal of the extract. Significant increase in body weight was recorded in groups III, IV and V compared to group II at P < 0.01, 0.001 and 0.05 respectively. Conclusion: The findings may indicate anti-diabetic effects of the extract which may be due to certain mineral elements and phytochemicals, and increase in weight in could be due to proper nutrient utilization probably induced by the avocado seeds’ extract. Avocado seeds may be of beneficial effects to diabetic patients.
Content may be subject to copyright.
Greener Journal of Medical Sciences ISSN: 2276-7797 Vol. 2 (1), pp. 005-011, January 2012.
www.gjournals.org
5
Research Article
Effects of aqueous avocado pear (Persea americana)
seed extract on alloxan induced diabetes rats
*A. J. Alhassan, M. S. Sule, M. K. Atiku, A. M. Wudil, H. Abubakar, S. A.
Mohammed
*Department of Biochemistry, Bayero University, Kano
Corresponding Author. Email: ajalhassan@yahoo.com Mobile phone: 08057623018
ABSTRACT
Background: world is facing explosive increase in diabetes mellitus. It poses a serious challenge to primary health care in
developing countries, with negative consequences on the economy. This research is aim at evaluating the effect of Persea
americana aqueous seed extract on alloxan induced diabetes rats.
Methodology: Effects of the aqueous extract on groups of alloxan (150mg/Kg) induced diabetic rats was investigated. The blood
sugar and body weight of the rats was recorded at two weeks and four weeks interval, and one week after the withdrawal of the
extract. The test groups (III, IV, and V) were treated with 400mg, 800mg and 1200mg/kg body weight of the extract for 4 weeks.
Results: A significant decrease (P<0.001) in blood glucose were observed in all groups compared to Group II. A significant
increase in blood glucose (p<0.05) was observed one week after withdrawal of the extract. Significant increase in body weight
was recorded in groups III, IV and V compared to group II at P < 0.01, 0.001 and 0.05 respectively.
Conclusion: The findings may indicate anti-diabetic effects of the extract which may be due to certain mineral elements and
phytochemicals, and increase in weight in could be due to proper nutrient utilization probably induced by the avocado seeds’
extract. Avocado seeds may be of beneficial effects to diabetic patients.
Key Words: Avocado pear (Persea americana) seed, Alloxan, Diabetes, Serum glucose.
INTRODUCTION
Medicinal plant have continued to attract attention in the global search for effective methods of using plants’ parts
(e.g. seeds, stems, leaves, roots and bark etc) for the treatment of many diseases affecting humans (Sofowora,
1993). Many important drugs used in medicine to day are directly or indirectly derived from plants due to its bioactive
constituents such as; alkaloids, steroids, tannins e.t.c (Cordeiro and Oniyangi, 1998). In recent years, secondary
plant metabolites previously with unknown pharmacological activities have been extensively investigated as sources
of medicinal agents (Krishnaraju et al., 2005).Thus it is anticipated that phytochemicals with adequate antimicrobial
efficacy will be use for treatment of bacterial infections (Balandrin et al., 1985).
Persea americana (luraceae) is one of the 150 varieties of avocado pear. The tree is widely cultivated in
tropical and subtropical areas (Lu et al., 2005). The seed of Persea americana (avocado seed) has diverse
application in ethno–medicine, ranging from treatment for diarrhea, dysentery, toothache, intestinal parasites, skin
treatment and beautification. The avocado seed oil has several health benefit e.g. for controlling human weight
(especially used for obese for weight loss) (Lopez et al., 1996; Roger, 1999). Persea americana leaves have been
reported to have or posses anti inflammatory and analgesic activities (Adeyemi et al., 2002). Antioxidant activity and
phenolic content of seeds of avocado pear was found to be greater than 70% (Soong and Barlow, 2004). The edible
part (fruit) is very popular in vegetarian cuisine, making a substitute for meat in sandwiches and salads, because of
its high fat content and high in valuable, health-promoting fats (Lu et al., 2005) . The fruit is not sweet but fatty,
almost distinctly, yet subtly flavored, and of smooth, almost creamy texture. Avocado fruits in many countries such as
Mexico, Brazil, South Africa and India are frequently used for milkshakes and occasionally added to ice-cream
(Zeldes, 2010).
Diabetes mellitus is often described as a group of complex metabolic disorders with a partial or absolute
insufficiency of insulin secretion and/or its action. These disorders are generally characterized by chronic
hyperglycemia and glucose intolerance (Naim et al., 2001). Diabetes mellitus is considered to be a bi-hormonal
disease involving insulin deficiency or defect in its utilization (e.g. receptor abnormality or presence of antibody to
Greener Journal of Medical Sciences ISSN: 2276-7797 Vol. 2 (1), pp. 005-011, January 2012.
www.gjournals.org
6
receptors) together with glucagon excess (Naim et al., 2001). Diabetes is one of the most common non–
communicable diseases in the world, affecting 5 to 10% of the adult population in the western world and hence,
representing a major cause of morbidity and mortality (Naim et al., 2001). There are two severe types of diabetes
mellitus, i.e. Type 1 or juvenile onset or insulin dependent diabetes mellitus (IDDM) and Type 2 or adult onset also
known as non–insulin dependent diabetes mellitus (NIDDM). In Type I diabetes; there is absence of insulin and
massive B-cells lesion and necrosis (Eisenberth, 2008). The Type 2 diabetes is characterized by a significant insulin
production ranging from less than normal to above normal but always in quantities insufficient to maintain glucose
homeostasis and organ resistance to insulin (Ripson, 2009). The characteristics symptoms of diabetes mellitus
includes excess thirst, polyphagia, polyurea, loss of body weight, frequent occurrence of boils, itching in the limbs,
and crowding around urine and impotence (WHO, 2003). This study is to evaluate effect of Persea Americana
aqueous seed extract on alloxan induced diabetes rats.
METHODOLOGY
Experimental Design
Twenty five (25) albino wistar rats weighing 180 – 220g were kept at Animal House of the Department of Biological
sciences, Bayero University, Kano Nigeria at 25 ± 2oC and 45-55 relative humidity. The animals were fed with
palletized commercial rat feed (Pfizer livestock co. Ltd, Aba, Nigeria) and tap water ad libitum. The rats were
assigned into five (5) groups of five (5) rats each as given below:
GROUP I
Normal untreated albino rats (NC)
GROUP II
Diabetic untreated albino rats (DC)
GROUP III
Diabetic treated albino rats (DGI), 400mg/Kg dose
GROUP IV
Diabetic treated albino rats (DGII), 800mg/Kg dose
GROUP V
Diabetic treated albino rats (DGIII), 1200mg/Kg dose
The baseline blood glucose level was determined, before groups II to V were induced with diabetes by intraperitoneal
(IP) injection of 150mg/kg body weight of alloxan monohydrate solution (Yanarday and Colac, 1998). The levels of
blood glucose of the animals were determined 48 hours after the injection using Glucometer (ACCU CHEK{Aviva})
model GMbH, 68298, those found to be diabetic (serum glucose
200mg/l) were selected for the study. The weight
of the experimental animals was noted before the inducement, after the inducement and at interval of two weeks for
four weeks during extract administration.
Sample Collection and Preparation
Samples of ripe Avocado pears (Persea Americana) were purchased from Sabon Gari Market, Fagge local
government Kano State, Nigeria. The plant material was authenticated at Department of Biological Sciences, Bayero
University, Kano, Nigeria. The succulent part of the fruit was removed to obtain the seeds. The seeds were minced
by means of a grater and dried to constant weight in an oven at 55oC before being ground to powder and stored in
plastic container. Aqueous extract was prepared and adjusted to concentration of 0.4 g/cm3. Diabetes rats of groups;
DGI, DGII and DGIII) were orally treated daily with 400mg; 800mg and 1200mg/kg body weigh with the extract
respectively for four weeks, while DC and NC groups were garaged with normal tap water. Their blood glucose was
determined at interval of two weeks. The extract was then withdrawn and the blood glucose level was determined
one week after.
Statistical Analysis
The data was statistically analysed using GraphPad Instat3 Software (2000) version 3.05. by GraphPad Inc..
RESULTS AND DISCUSSION:
Table 1 show blood glucose mmol/l for groups of rats induced with diabetes and treated with aqueous seed extract of
avocado seed for zero, two four weeks and one week after withdrawal of the extract. The One-way Analysis of
Variance (ANOVA) for normal gave a P value of 0.9950 (P>0.05.) hence considered not significant; therefore
variation among column means is not significantly greater than expected by chance.
Greener Journal of Medical Sciences ISSN: 2276-7797 Vol. 2 (1), pp. 005-011, January 2012.
www.gjournals.org
7
Table 1: Blood glucose in mmol/l of alloxan induced diabetes rats orally treated with aqueous seed extract of Avocado
Americana for one 14 days, 28 days and 7days after withdrawal of the treatment.
Group Normal ZWKS TWKS FWKS OWAFWD
I , n
0mg/Kg alloxan
4.80
±
0.61
4.80
±
0.41
4.70
±
0.51
4.70
±
0.55
4.70
±
0.64
II, n
0mg/kg
4.7
±
0.50
26.50
±
4.04
27.90
±
4.34
28.90
±
4.25
28.90
±
4.05
III, n
400mg/Kg
4.70
±
0.50
25.80
±
7.16
12.70
±
5.01
10.50
±
3.47
14.87
±
1.62
IV, n
800mg/Kg
5.60
±
0.32
26.30
±
3.39
18.70
±
2.49
16.90
±
2.82
20.00
±
3.19
V, n
1200mg/Kg
5.20
±
0.70
24.40
±
0.68
8.50
±
1.15
6.60
±
1.00
13.70
±
3.01
Values are mean ± standard deviation, n=5
Key:
Normal= before induced with diabetes
ZWKS = 0 week after inducement with diabetes
TWKS = 2 weeks after inducement with diabetes
FWKS = 4 weeks after inducement with diabetes
OWAFWD = 1 weeks after withdrawal of treatment
ANOVA assumes that the data are sampled from populations (GI) with identical SDs. This assumption is tested using
the method of Bartlett (2000) given P value of 0.9345 (P>0.05), thereby suggesting that the differences among the
SDs are not significant. The statistical conclusion is expected since G I and normal columns were neither treated with
alloxan nor with aqueous extract of avocado seeds. Hence whatever variation recorded in any of the; groups or
columns could be as a result of the treatment.
ANOVA for ZWKS had a P < 0.0001, variation among column means (GI vs GII, III, IV and V) is considered
extremely significant and this may confirm inducement of diabetic among alloxan treated groups. Table 2: Show
Tukey-Kramer multiple comparisons test for Group II and variation among raw means (Normal vs Zwks, Twks, Fwks
and OWAFWD) is considered significant (P<0.001), while variation in raw mean among alloxan induced diabetic rats
with time is not significantly different (P>0.05). This may confirm inducement of diabetic condition in the alloxan
treated groups and it lasted throughout the study period. This out come should be expected since the group was not
treated with extract and show no evidence of natural healing (Table1and 2).
Table 2: Tukey-Kramer Multiple Comparisons Test, for different period in Group II
Mean
Comparison difference q p value
=================================================================
Norm vs Zwks -21.800 13.040 *** P<0.001
Norm vs Twks -23.200 13.877 *** P<0.001
Norm vs Fwks -24.200 14.475 *** P<0.001
Norm vs OWAFWD -24.200 14.475 *** P<0.001
Zwks vs Twks -1.400 0.8374 ns P>0.05
Zwks vs Fwks -2.400 1.436 ns P>0.05
Zwks vs OWAFWD -2.400 1.436 ns P>0.05
Twks vs Fwks -1.000 0.5982 ns P>0.05
Twks vs OWAFWD -1.000 0.5982 ns P>0.05
Fwks vs OWAFWD 0.000 0.000 ns P>0.05
If the value of q is greater than 4.232 then the P value is less than 0.05 and is specified by the script ٭٭٭
Greener Journal of Medical Sciences ISSN: 2276-7797 Vol. 2 (1), pp. 005-011, January 2012.
www.gjournals.org
8
ANOVA for TWKS, is considered extremely significant (P < 0.0001) therefore, variation among column means is
significantly greater than expected by chance. This could be due to treatment given to group III, IV and V. Table 3
show the outcomes on comparing variation in blood sugar in group III with duration of treatment. The non significant
difference for Norm vs Twks, and Norm vs Fwks is indicating probable glucose lowering effect of avocado aqueous
seed extract on alloxan induced diabetes rats. While, the significant different (p<0.01) in Norm vs OWAFWD is
indicating that the avocado extract may have management effects but not curative. The significant difference (p<
0.001) for Zwks vs Twks, and Zwks vs Fwks had confirmed the glucose lowering effect of the extract when compared
with that of the diabetes rats before treatment. The significant difference at p <0.01 for Zwks vs OWAFWD is
indicating that the blood glucose level rising one week after the withdrawal of the treatment, therefore, confirmed
management effect of the extract.
Table 3: Tukey-Kramer Multiple Comparisons Test, for different period in Group III
Mean
Comparison Difference q P value
================================================================
Norm vs Zwks -21.100 1.042 *** P<0.001
Norm vs Twks -8.000 4.187 ns P>0.05
Norm vs Fwks -5.800 3.035 ns P>0.05
Norm vs OWAFWD -10.170 5.322 ** P<0.01
Zwks vs Twks 13.100 6.856 *** P<0.001
Zwks vs Fwks 15.300 8.007 *** P<0.001
Zwks vs OWAFWD 10.930 5.720 ** P<0.01
Twks vs Fwks 2.200 1.151 ns P>0.05
Twks vs OWAFWD -2.170 1.136 ns P>0.05
Fwks vs OWAFWD -4.370 2.287 ns P>0.05
If the value of q is greater than 4.232 then the P values is less than 0.05 and are specify by the script (٭) base on p
value.
ANOVA for FWKS shows extremely significant variation (P < 0.0001) among column means greater than
expected by chance, it could be due to treatment given to group III, IV and V. Table 4 gives the assumption test for
GIV, ANOVA ‘assumes that the data are sampled from populations with identical SDs’. This assumption is tested
using the method of Bartlett (2000). Bartlett statistic (corrected) = 12.650, the P value is 0.0131, Bartlett's test
suggests that the differences among the SDs is significant. From Tables 1 and 4, the significant (p<0.001) variation in
Norm vs Twks, and Norm vs Fwks despite treatment with higher dose compared to Group III (Table 4, is unexpected
this could be due to the time difference between feeding and glucose determination. However, the significant
difference at p<0.01, 0.001 and 0.05 respectively for Zwks vs Twks, Zwks vs Fwks and Zwks vs OWAFWD also
indicated the hypoglycemic effects of the extract on alloxan induced diabetes rats.
Table 4: Tukey-Kramer Multiple Comparisons Test, for different period in Group IV
Mean
Comparison Difference q P value
=================================================================
Norm vs Zwks -20.700 17.268 *** P<0.001
Norm vs Twks -13.100 10.928 *** P<0.001
Norm vs Fwks -11.300 9.427 *** P<0.001
Norm vs OWAFWD -14.400 12.013 *** P<0.001
Zwks vs Twks 7.600 6.340 ** P<0.01
Zwks vs Fwks 9.400 7.842 *** P<0.001
Zwks vs OWAFWD 6.300 5.256 * P<0.05
Twks vs Fwks 1.800 1.502 ns P>0.05
Twks vs OWAFWD -1.300 1.084 ns P>0.05
Fwks vs OWAFWD -3.100 2.586 ns P>0.05
If the value of q is greater than 4.232 then the P values is less than 0.05 and are specify by the script (٭) base on p
value.
Greener Journal of Medical Sciences ISSN: 2276-7797 Vol. 2 (1), pp. 005-011, January 2012.
www.gjournals.org
9
One-way Analysis of Variance (ANOVA) for OWAFWD shows that variation among column means is significantly
greater than expected by chance (P < 0.0001). Table 5 shows the out comes for ANOVA that ‘assumes that the data
are sampled from populations with identical SDs’. This assumption is tested using the method of Bartlett. Bartlett
statistic (corrected) = 12.786, the P value is 0.0124. Bartlett's test suggests that the differences among the SDs are
significant. None significant (p>0.05) difference in Norm vs Fwks may suggest that the hypoglycemic effect of the
avocado seed extract is based on dose and duration of exposure.
Table 5: Tukey-Kramer Multiple Comparisons Test, for different period in Group V
Mean
Comparison Difference q P value
==================================================================
Norm vs Zwks -9.200 13.097 *** P<0.001
Norm vs Twks -3.300 4.698 * P<0.05
Norm vs Fwks -1.400 1.993 ns P>0.05
Norm vs OWAFWD -8.500 12.101 *** P<0.001
Zwks vs Twks 5.900 8.399 *** P<0.001
Zwks vs Fwks 7.800 11.104 *** P<0.001
Zwks vs OWAFWD 0.7000 0.9965 ns P>0.05
Twks vs Fwks 1.900 2.705 ns P>0.05
Twks vs OWAFWD -5.200 7.403 *** P<0.001
Fwks vs OWAFWD -7.100 10.108 *** P<0.001
If the value of q is greater than 4.232 then the P value is less than 0.05 and is specify by the script (٭) base on p
value.
Table 6: weight (g) of alloxan induced diabetes rat orally treated with aqueous extract of avocado seeds
for 2 and 4 weeks, and 1 week after withdrawal of treatment
Group
ZWKS
TWKS
FWKS
OWAFWD
I
0mg/Kg alloxan
180
.0
±
1.13
180
.0
±
1.20
183.3
±
4.08
206.7
±
8.17
220
.0
±
14.14
II
0mg/kg
180
.0
±
1.300
176.7
±
4.08
170.
0
±
7.07
163.3
±
3.7.3
156.7
±
3.73
III
400mg/Kg
193.3
±
7.45
186.7
±
17
216.7
±
10.80.
22
0.
0
±
14.14
213.3
±
16.33
IV
800mg/Kg
200
.0
±
0.00
186.7
±
17
206
.7
±
8.17
220
.0
±
14.14
220
.0
±
14.14
V
1200mg/kg
200
.0
±
0.00
193.3
±
8. 17
200
.0
±
0.00
201.3
±
8.17
206.7
±
17
Values are mean standard deviation, n=5
Greener Journal of Medical Sciences ISSN: 2276-7797 Vol. 2 (1), pp. 005-011, January 2012.
www.gjournals.org
10
Table 7: Tukey-Kramer Multiple Comparisons Test for weight (g) of normal, diabetes; treated and untreated,
and one week after withdrawal of the treatment diabetes rats
Mean
Comparison Difference q P value
=============================================================
GI vs GII 24.660 4.137 ns P>0.05
GI vs GIII -11.980 2.010 ns P>0.05
GI vs GIV -16.680 2.799 ns P>0.05
GI vs GV -6.266 1.051 ns P>0.05
GII vs GIII -36.640 6.147 ** P<0.01
GII vs GIV -41.340 6.936 *** P<0.001
GII vs GV -30.926 5.189 * P<0.05
GIII vs GIV -4.700 0.7886 ns P>0.05
GIII vs GV 5.714 0.9587 ns P>0.05
GIV vs GV 10.414 1.747 ns P>0.05
If the value of q is greater than 4.232 then the P value is less than 0.05 and is specify by the script (٭) base on p
value
Hypoglycemic effect of the avocado seed extract may be due probable contents of elements such as calcium,
magnesium, potassium, sodium, zinc, chromium e.t.c that play key role in blood glucose homeostasis by regulating
the key enzymes involved in gluconeogenesis in the liver e.g. glucose-6- phosphatase, fruitcose-1, 6-
bisphosphatatase and phosphoenolpyruvate carboxykinase, thereby blocking gluconeogenesis and enhancing
glucose utilization in the body (Broadhust, 1997). The seed may in addition to these elements contains certain
hypoglycemic agents such as phytochemicals (e.g. flavonoids, saponins, steroids, terpenoids, tannins and alkaloids
etc) which contain insulin stimulatory substances such as insulin receptors substrate (IRS), prohornone convertase,
glycogen synthase, the b3 adrenergic receptor, glucose dependent insulinotrophic polypeptide (GIP) receptor and
peroxisome proliferators – activated receptor gamma e.t.c. (Broadhust, 1997). However, the mechanism by which the
extract lowered the blood glucose level in alloxan induced diabetic rats is still unclear. It could be by stimulating
peripheral utilization of glucose by inhibiting absorption in the gastrointestinal tract (GIT), increasing glucose
metabolism, or regenerating the pancreatic tissue or potentiating the insulin secretion by the surviving B- cells. A
prolonged administration of the extract shows higher hypoglycemic effects on alloxan induced diabetic rats than are
shorter period. And after withdrawal of the treatment for one week the blood glucose gradually rised, however below
that of the untreated group, this signifies the management effect of the avocado seed extract.
The increase in weight of diabetic rats treated with avocado seed extract (Table 6) was found to be
significant between diabetes groups treated with avocado seed and diabetic non treated (Group II). This could be
due to certain compounds and or mineral elements that may stimulate effective utilization of nutrients. In addition, the
seed may contain nutrients such as protein and fat this coupled with their effective utilization, may be responsible for
the weight gain.
CONCLUSION
The findings of this study indicate that consumption of the aqueous extract of avocado pear seed (Persea americana)
exerts significant hypoglycemic effects on alloxan induced diabetic rats. The findings may support acclaimed
traditional use of avocado pear seed for controlling hyperglycemia in diabetes. The findings also indicate that
prolonged oral administration of aqueous extracts of avocado pear seed has a greater effect in management of
diabetes mellitus than short term administration.
REFERENCES:
Adeyemi, O.O., Okpo, S.O. and Ogunti O.O. (2002): Analgesic and anti-inflammatory effect of the aqueous extract of
leaves of Persea americana Mill (Lauraceae). Fitoterapia 73: 375–380.
Balandrin, M.F., Kjocke A.J and Wurtele, D.F (1985): Natural Plant chemicals sources of Industrial and
Pharmaceutics, Humana press, New Jersey USA; Pp. 137-141.
Greener Journal of Medical Sciences ISSN: 2276-7797 Vol. 2 (1), pp. 005-011, January 2012.
www.gjournals.org
11
Broadhurst, C.L. (1997). Nutrition and non insulin diabetes mellitus form by the combined administration of
streptozotocin or alloxan and poly (adenosine diphosphate ribose). Engg. 2: 125
Codeiro N. J. V. and Oniyangi, O. (1998). Phytomedicines. 2nd Edition. Pp. 200-2005.
Eisenbarth, S., Polonsky, S. and Buse, B. (2008). Type 1 Diabetes Mellitus. In: Williams Textbook of Endocrinology.
11th ed. Philadelphia, Pa: Saunders Elsevier; p. 31.
Krishnaraju, A.V., Rao T.V. and Sundararaju. A. (2005): Assessment of bioactivity of Indian medicinal plants using
Brine shrimp (Altenaria salania) lethality assay. Int. J. Appl. Sci. Int. J. Appl. Sci Engg. 2: 125-134.
Lopez, R., Frati, C., Hernandez, C., Cervantes, S., Hernandez, H., Juarez, C. and Moran, S. (1996).
"Monounsaturated fatty acid (avocado) rich diet for mild hypercholesterolemia". Arch-Med-Res,. 27 (100) :678-
701.s
Lu Q.Y., Arteaga, J. R, Zhang, Q., Huerta, S., Go, V.L and Heber, D. (2005): Inhibition of prostate cancer cell growth
by an avocado extract: role of lipid-soluble bioactive substances. J. Nutr. Biochem. 16: 23-30.
Naim, S. Raanan, S. Moshe, B. Amos, E. (2001). "Insulin in human milk and the prevention of type 1 diabetes".
Pediatric Diabetes 2 (4): 175–7.
Rees, D. A. and Alcolado, J.C. (2005). Animal models of diabetes mellitus. Diabetic Medicine. 22:359-370.
Ripsin, M., Kang, H. and Urban, R. (2009). "Management of blood glucose in type 2 diabetes mellitus.” American
family physician 79 (1): 29-36.
Roger, C. R. (1999) The nutritional incidence of flavonoids: some physiologic and metabolic considerations.
Experientia 44 (9):725-804.
Sofowora, A. (1993). Medicinal Plants and Traditional in Africa 2nd ed. Spectrum Book Limited, Ibadan. Pp. 6 – 188.
Song, Y. and Barlow, P. J. (2004): Antioxidant activity and phenolic content of selected fruit seeds. Food Chem.,
88(3):411–417
WHO/FAO. Diet, nutrition, and the prevention of chronic diseases. Geneva: World Health Organization, 2003.
Yanarday R. and Colac H. (1998). Effect chard (Beta vulgaris L. varcicla ) on blood glucose level in normal and
alloxaninduced diabetic rabbit. J. Ethnopham. 4:309-311.
Zeldes, L. A. (2010). "Eat this! The ‘Hass avocado, black and green and creamy". Dining Chicago. Chicago's
Restaurant & Entertainment Guide, Inc.
... In another study, where the aqueous extract of Persea americana Mil. seed was also evaluated, they demonstrated a significant reduction in blood glucose levels (51%) and an increase in body weight (12%) in diabetic rats, with doses of 400, 800, 1200 mg/kg (Table 4) [64]. ...
... Persea americana Mil. can cause a hypoglycemic effect [60,[62][63][64][65]67,68], as well as an increase in insulin sensitivity [69], an improvement in pancreatic β-cell function and histology [63,65,66], and an increase in insulin levels [68,69] (Table 4). ...
... In the reviewed articles, Persea americana Mil. restored the body weight loss caused by diabetes [61,62,[64][65][66]68]. In one of the articles, it was mentioned that this plant could also cause body weight loss in a model of obese mice; this may be due to the benefits that avocatin B could present in glucose and fat metabolism [69]. ...
Article
Full-text available
Background: Obesity is defined as abnormal or excessive fat accumulation, provoking many different diseases, such as obesity and type 2 diabetes. Type 2 diabetes is a chronic-degenerative disease characterized by increased blood glucose levels. Obesity and type 2 diabetes are currently considered public health problems, and their prevalence has increased over the last few years. Because of the high cost involved in the treatment of both diseases, different alternatives have been sought. However, the general population uses medicinal plants, in the form of tea or infusions, to treat different diseases. Therefore, traditional medicine using medicinal plants has been investigated as a possible treatment for type 2 diabetes and body weight control. Aim of the study: The purpose of this review is to find medicinal plants used in Mexico that could exert their beneficial effect by regulating insulin secretion and body weight control. Material and method: For the development of this review, Mexican plants used in traditional medicine to treat type 2 diabetes and body weight control were searched in PubMed, Google Scholar, and Scopus. The inclusion criteria include plants that presented a significant reduction in blood glucose levels and/or an increase in insulin secretion. Results: We found 306 Mexican plants with hypoglycemic effects. However, plants that did not show evidence of an increase in insulin secretion were eliminated. Finally, only five plants were included in this review: Momordica charantia L. (melón amargo), Cucurbita ficifolia bouché (chilacayote), Coriandrum sativum L. (cilantro), Persea americana Mill. (aguacate) Bidens pilosa (amor seco), including 39 articles in total. Here, we summarized the plant extracts (aqueous and organic) that have previously been reported to present hypoglycemic effects, body weight control, increased secretion and sensitivity of insulin, improvement of pancreatic β cells, and glucose tolerance. Additionally, these effects may be due to different bioactive compounds present in the plants' extracts. Conclusion: Both in vivo and in vitro studies are required to understand the mechanism of action of these plant extracts regarding insulin secretion to be used as a possible treatment for type 2 diabetes and body weight control in the future.
... Ebifa et al. [17] showed that the aqueous extract of avocado pear significantly reduced glycemia in diabetic-treated rats compared with non-treated rats. This is in agreement with the findings of Alhassan et al. [18]. The anti-diabetic effects of the extract may be due to the availability of minerals such as calcium, zinc, magnesium, etc., as these play a vital role in blood glucose homeostasis. ...
... An elevation in the blood glucose levels of the diabetic rats was confirmed, validating the successful induction of DM. The reduction in fasting blood glucose levels caused by AEAMP at various dosages could be due to pancreatic β-cell restoration, and the findings are consistent with previous research indicating the extract's potential for hypoglycemic activity [55,56]. ...
Article
Full-text available
Background and objective Annona muricata L. peel has been recognized for many ethnobotanical uses, including diabetes management. However, limited detailed scientific information about its mechanism of antidiabetic activity exists. The objective of this study was to evaluate the anti-diabetic properties of an aqueous extract of A. muricata peel (AEAMP) and its mechanism of action on alloxan-induced diabetic rats. Methods In vitro antidiabetic assays, such as α-amylase and α-glucosidase were analyzed on AEAMP. Alloxan monohydrate (150 mg/kg b.w) was used to induce diabetes in the rats. 150 mg/kg b.w positive control group doses of 6.67, 13.53, and 27.06 mg/kg were administered to 3 groups for twenty-one days. The positive control group was administered 30 mg/kg of metformin. The negative and normal control groups were administered distilled water. The fasting blood glucose, serum insulin, lipid profile, inflammatory cytokines, antioxidant markers, carbohydrate metabolizing enzymes, and liver glycogen were analyzed as well as PI3K/AKT and apoptotic markers PCNA and Bcl2 by RT-PCR. Results AEAMP inhibited α-amylase and α-glucosidase enzymes more effectively than acarbose. AEAMP reduced FBG levels, HOMA-IR, G6P, F-1,6-BP, MDA, TG, TC, AI, CRI, IL-6, TNF-α, and NF-κB in diabetic rats. Furthermore, in diabetic rats, AEAMP improved serum insulin levels, HOMA-β, hexokinase, CAT, GST, and HDL-c. Liver PI3K, liver PCNA and pancreas PCNA were not significantly different in untreated diabetic rats when compared to normal rats suggesting alloxan induction of diabetes did not downregulate the mRNA expression of these genes. AEAMP significantly up-regulated expression of AKT and Bcl2 in the liver and pancreatic tissue. It is interesting that luteolin and resorcinol were among the constituents of AEAMP. Conclusions AEAMP can improve β-cell dysfunction by upregulating liver AKT and pancreatic PI3K and AKT genes, inhibiting carbohydrate metabolizing enzymes and preventing apoptosis by upregulating liver and pancreatic Bcl2. However, the potential limitation of this study is the unavailability of equipment and techniques for collecting more data for the study.
... As proof, seeds of mango have a broad range of medicinal properties, such as antimicrobial, antiviral, antifungal, anti-inflammatory, anti-diarrhoeal, antioxidant, as well as immunomodulatory 12,13,14,15,16,17 . The biological activities such as antioxidant, antihypertensive, fungicidal, larvicidal, hypolipidemic, amoebicidal and giardicidal activities of the seeds of avocado had also reported 18,19,20,21,22,23,24 . No study on the two seeds in Benin has been undertaken with a view to their valorization. ...
Article
Full-text available
Background: Mangiferaindica L. and Persea Americana L. are two fruit trees very well-known and appreciated by the people of Benin for their fruits. The seeds from the fruits of these plants, despite their growing interest in pharmacology, are considered as environmental waste not yet recovered. This work aims to determine the phytochemical composition and the antimicrobial activity of the ethanolic extract of these two neglected seeds in Republic of Benin. Materials and Methods:50 g of powder of P. Americana and M. indicaseeds were separately crushed and recovered in 500 ml of ethanol 96°C to obtain their extracts. The qualitative and quantitative phytochemical screening was performed to determine the different phytochemical groups. Antimicrobial activity was performed on eleven bacteria to determine theinhibitory diameter zone, the Minimum Inhibitory Concentrations and the inimum Bactericidal Concentration Results: Qualitative and quantitative phytochemical analysis of the ethanolic extract revealed that avocado seeds extract contained alkaloids: 2.14 ± 0.012 mg, flavonoids: 5.33 ± 0.064 mg, reducing compounds: 0.84 ± 0.027 mg and phenolic compounds 3.22 ± 0.035 mg. That of mango seeds also included alkaloids: 2.14 ± 0.012 mg of flavonoids, 5.33 ± 0.064 mg of reducing compounds 1.72 ± 0.019 mg and phenolic compounds (7.68 ± 0.027 mg). Antimicrobial tests indicated a larger inhibition diameter (25mm)and shown a lower minimum inhibitory concentration of (0.325 mg / ml) on certain bacteria with the two extracts. The mango extract had a bactericidal effect (1.25 mg / ml) on Staphylococcus epidermidis T22695. Conclusion: The extracts of the two seeds, rich in chemical compounds and having interesting antimicrobial properties could constitute sources of active principles in the development of antimicrobial agents.
Article
Full-text available
Avokado, Plantae krallığına, Lauraceae ailesine, Laurales takımına, Persea cinsine ve P. americana türüne ait bir bitkidir. İçeriğindeki zengin biyoaktif bileşenlerin ve besin öğelerinin sağlık üzerine yararlı etkileri olduğu bilinen ve süper gıda olarak kabul edilen bitkisel kaynaklı bir gıdadır. Avokado ağacının; meyvesinin eti ve kabuğu, yaprağı ve çekirdeği zengin biyoaktif bileşenler içermektedir. Meyve çekirdeği (%16) ve kabuğu (%11) bazı çeşitlerde istisnalar olmak üzere meyvenin %21-30’unu temsil eden miktarlarda katı atık oluşturmaktadır. Avokadoda en yaygın bulunan biyoaktif bileşenler polifenoller, karotenoitler, tokoferoller ve sterollerdir. Polifenoller meyve eti, kabuk, tohum ve yapraklarda; karotenoitler ve tokoferoller ise avokado meyvesinin etinde bulunmaktadır. Avokadonun zengin biyoaktif içeriğinin metabolik sendrom hastalıklarına, hipoglisemik, antihipertansif, antioksidan, obezite, hiperlipidemik, antimikrobiyal, antiprotozoal ve antimikobakteriyel vb. hastalıklara etkisi literatürde ilgi çeken bir konu haline gelmiştir. Özellikle avokado atıklarından çekirdeğinin, meyvesinin kabuğunun ve yaprağının larvisidal, antifungal, antimikrobiyal, antioksidan, antiprotozoal, antidiyabetik, antihipertansif, hiperkolesterolemik ve antimikobakteriyel aktiviteler gibi birçok hastalığı durdurucu/yavaşlatıcı etkisinin olduğu bildirilmiştir. Bu derlemede, avokado ağacının; meyvesinin eti ve kabuğunun, yaprağının ve çekirdeğinin biyoaktif bileşenleri ve bu bileşenlerin sağlık üzerine etkileri incelenecektir.
Article
Full-text available
Activity of α-glucosidase enzyme in the gastrointestinal tract has been implicated in postprandial hyperglycaemia. If not properly controlled, postprandial hyperglycaemia might progress to diabetes mellitus, a metabolic syndrome. Diabetes is associated with many complications such as retinopathy, heart attack, nephropathy, neuropathy, stroke, and lower limb amputation. Antidiabetic medications presently in use have little effect on postprandial glycaemic excursion and hence do not bring down the blood glucose level to baseline. This study extracted, fractionated, and screened the aqueous extract of Persea americana seeds for hypoglycaemic potential. Inhibitory effects of the fractions and subfractions of the extract on α-glucosidase activity were investigated. The most active subfraction was subjected to Fourier transform infrared (FTIR) and gas chromatography mass spectroscopy (GC-MS) analysis to elucidate the active components. The active subfraction showed a significant inhibition ( p < 0.05 ) on α-glucosidase. The subfraction competitively inhibits α-glucosidase (with IC50 = 09.48 ± 0.58 μg/mL), though less potent than the standard drug, acarbose (IC50 = 06.45 ± 0.47 μg/mL). FTIR analysis of the subfraction showed the presence of carbonyl group, hydroxy group, carboxyl group, double bonds, methylene, and methyl groups. GC-MS analysis suggests the presence of cis-11,14-eicosadienoic acid, catechin, and chlorogenic acid as the active components. In conclusion, the components obtained from this study can be synthesised in the laboratory to further confirm their hypoglycaemic activity. The most active subfraction can be explored further to confirm its inhibitory activity against the enzyme and to determine its extent in the treatment of diabetes mellitus in vivo.
Article
Full-text available
Background: Type 2 Diabetes Mellitus (DMT2) is one of the most common non-communicable diseases (NCDs) worldwide. T2DM is also the leading cause of death in most developed and developing countries. Objective: This study aimed to analyze the effect of avocado (Persea americana Mill.) skin extract on blood glucose levels in white male rats with diabetes (preclinical test). Method: Experimental research in vivo with True Experimental-PreTest and Post Test Only Control Group Design. The samples were 15 white male rats aged ±3 months, with a 150-200 grams bodyweight. Avocado peel was extracted with ethanol. Measurement of fasting blood glucose levels was carried out 3 times. Streptozotocin administration was used to increase glucose levels in experimental animals. Data analysis used Analysis of Variance (ANOVA) to analyze the data obtained from each treatment group, and the level of significance was expressed in =5%. Results: Fasting blood glucose levels in the first measurement for all groups were included in the normal category, about 48.73 mg/dL. Then the second measurement after being induced with STZ showed an increase in fasting blood glucose levels of mice with an average of 181.07 mg/dL. Furthermore, the 3rd measurement showed that mice's fasting blood glucose level was still high, except for group IV, which decreased to 97.33 mg/dL. The results of the comparative analysis of fasting blood glucose levels on the 2nd and 3rd measurements showed that most of them experienced a decrease, except in group V, and the intervention group which experienced a significant decrease, group IV with p-value = 0.003 and the magnitude of the decrease was 133.33 mg/dL. Conclusion: The concentration of 200 mg/kg BW of avocado peel extract significantly reduced fasting blood glucose levels by 133.33 mg/dL after STZ induction compared to other groups
Chapter
The avocado (Persea Americana Mill.), a pear-shaped fruit, is a member of the family Lauraceae. It is a tropical native American fruit and is considered a functional food due to its unique bioactive compounds. Mexico is the largest producing country of avocado by over 30%, followed by Dominican Republic, Peru, Indonesia, Colombia, Kenya, United States of America, Rwanda, Chile, and Brazil. The use of the waste obtained after processing of avocado fruit presents an important economically viable avenue to be explored and utilized. A number of essential industrial products can be obtained from the avocado wastes, such as animal feed, oil, microbiological culture media, adsorbents/bioremediants, biocatalysts, biodiesel, starch, fuel, cosmeceuticals, and biopolymers. The waste extracts mainly from peels and seeds have anti-inflammatory, antimicrobial, antidiabetic, antihypertensive, anticancer, antioxidant, fungicidal, hepato-protective, and insecticidal activities, making them useful for a wide range of innovative nutraceutical applications. This chapter provides insight into composition, bioactivities, and potential food and non-food applications of the avocado by-products.
Chapter
Plant extracts have been used for thousands of years because of higher bioactive components, which are responsible for certain physiological activities in human body. Numerous phytochemicals exist in edible fruits, flowers, seeds, and leaves, which are related to health-promoting benefits like antioxidants, antiinflammatory, anticancer, hypoglycemic, antiobesity, and substances with protective properties of the neurological, hepatic, cardio, and gastro systems. Chemical components present in them have physiological functions in living plants, and hence they have superior compatibility with human body. Various examples of animal model studies are also discussed to show the potency of the plant extracts against several ailments. Overall, the existing evidence proves that, while there are suggestions of the probable values of plant extract consumption, additional studies on humans are required to verify a factual cause-effect. As the technology develops and our understandings on the mode of actions of such molecules increase, new applications will emerge.
Article
Full-text available
The hypoglycaemic effect of chard leaves (Beta vulgaris L. var. cicla) in normal and alloxan-induced diabetic rabbits was investigated.Blood glucose levels were determined after oral administration of various doses of aqueous and methanolic extracts of chard.In normal rabbits, 2gkg−1 aqueous chard extract significantly (P < 0.01) reduced blood glucose levels 4h after administration. In diabetic rabbits, 2, 4 and 8g kg−1 aqueous chard extract had a significant (P < 0.1) antihyperglycaemic effect. Methanolic extracts of chard had no significant effect on blood glucose in either group.
Article
Full-text available
The aqueous extract of Persea americana leaves produced a dose-dependent inhibition of both phases of formalin pain test in mice, a reduction in mouse writhing induced by acetic acid and an elevation of pain threshold in the hot plate test in mice. The extract also produced a dose-dependent inhibition of carrageenan-induced rat paw oedema. The results obtained indicate that the extract possesses analgesic and anti-inflammatory effects.
Article
The total antioxidant capacity and phenolic content of edible portions and seeds of avocado, jackfruit, longan, mango and tamarind were studied. In addition, the relationship between antioxidant activity, phenolic content and the different degrees of heating of mango seed kernel was investigated. The seeds showed a much higher antioxidant activity and phenolic content than the edible portions. The contribution of all the fruit seed fractions to the total antioxidant activity and phenolic content was always >70%. ABTS cation radical-scavenging and FRAP assays were employed for the determination of antioxidant activity; FCR assay was used to measure the total phenolic content. The AEAC and FRAP of ethanolic extracts of MSKP products increased to a maximum after heating to 160 °C. The total phenolic content in extracts of MSKP products increased from 50.3 to 160 mg/g GAE with an increase in heating temperature to 160 °C.
Article
Although controversial, exclusive breast milk feeding was shown to exert a protective effect in preventing type 1 diabetes. In contrast, an early introduction of cow's milk-based formula in young infants may enhance the risk of disease, especially in genetically susceptible children, presumably by an increase of intestinal permeability to macromolecules such as bovine serum albumin and β-casein, which may arouse autoimmunity. We have shown that human milk contains insulin in substantial concentrations, while insulin is barely detectable (if at all) in infant formulas. Orally administered insulin was demonstrated to promote gut maturation and to reduce intestinal permeability to macromolecules. Furthermore, oral insulin may induce tolerance to insulin and protect against the development of type 1 diabetes. We herewith raise a hypothesis that human milk is protective against the development of type 1 diabetes by virtue of the effects of its substantial content of insulin.
Article
Evidence-based guidelines for the treatment of type 2 diabetes mellitus focus on three areas: intensive lifestyle intervention that includes at least 150 minutes per week of physical activity, weight loss with an initial goal of 7 percent of baseline weight, and a low-fat, reduced-calorie diet; aggressive management of cardiovascular risk factors (i.e., hypertension, dyslipidemia, and microalbuminuria) with the use of aspirin, statins, and angiotensin-converting enzyme inhibitors; and normalization of blood glucose levels (hemoglobin A1C level less than 7 percent). Insulin resistance, decreased insulin secretion, and increased hepatic glucose output are the hallmarks of type 2 diabetes, and each class of medication targets one or more of these defects. Metformin, which decreases hepatic glucose output and sensitizes peripheral tissues to insulin, has been shown to decrease mortality rates in patients with type 2 diabetes and is considered a first-line agent. Other medications include sulfonylureas and nonsulfonylurea secretagogues, alpha glucosidase inhibitors, and thiazolidinediones. Insulin can be used acutely in patients newly diagnosed with type 2 diabetes to normalize blood glucose, or it can be added to a regimen of oral medication to improve glycemic control. Except in patients taking multiple insulin injections, home monitoring of blood glucose levels has questionable utility, especially in relatively well-controlled patients. Its use should be tailored to the needs of the individual patient.
Article
Examination of the physiological activity of flavonoids in relation to their antiscorbutic properties shows that some of these compounds, the flavan-3-ols, have a particular nutritional impact and consequently should be distinguished from the rest of the flavonoids and polyphenols. Therefore, the use of the term 'Vitamin P' and 'Bioflavonoids' is also discussed.
Article
To assess the effect of a high monounsaturated fatty acids (MFA) diet on serum lipids, 30 healthy adult normolipidemic volunteers and 37 adult patients with mild hypercholesterolemia (5.4-9.3 mmol/l), 15 of them also with hypertriglyceridemia (2.3-4.8 mmol/l), were studied. Fifteen healthy and 30 hypercholesterolemic subjects (15 of them with associated type 2 diabetes mellitus) received an avocado enriched diet (2000 Kcal, lipids 53% MFA 49 g saturated/unsaturated ratio 0.54), and seven non-diabetic hypercholesterolemic individuals received an isocaloric control diet (MFA 34 g, saturated/unsaturated ratio 0.7). Serum total cholesterol, LDL-cholesterol, HDL-cholesterol and triglyceride concentrations were measured before and after a 7-day diet period. In healthy individuals a 16% decrease of serum total cholesterol level followed the high MFA diet, while it rose after the control diet (p < 0.001 between diets). In hypercholesterolemic subjects a significant (p < 0.01) decrease of serum total cholesterol (17%), LDL-cholesterol (22%) and triglycerides (22%), and increase of HDL-cholesterol (11%) levels occurred with the avocado diet, while no significant changes were noticed with the control diet. High lipid, high MFA-avocado enriched diet can improve lipid profile in healthy and especially in mild hypercholesterolemic patients, even if hypertriglyceridemia (combined hyperlipidemia) is present.